SCHEMBL3343700

SCHEMBL3343700

Cc1ccc(N2CCCC2)cc1N

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100B P04271 2/20 0.61
MAPT P10636 8/20 0.56
ALDH1A1 P00352 7/20 0.56
MEN1 O00255 6/20 0.56
KMT2A Q03164 6/20 0.56
GAA P10253 5/20 0.56
LMNA P02545 3/20 0.56
ALOX15 P16050 3/20 0.56
HTT P42858 3/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
MAPK1 P28482 2/20 0.56
PKM P14618 1/20 0.56
IP6K1 Q92551 1/20 0.50
RAD52 P43351 1/20 0.49
KDM4E B2RXH2 4/20 0.48
NPSR1 Q6W5P4 3/20 0.48
RECQL P46063 3/20 0.48
HSD17B10 Q99714 3/20 0.48
THRB P10828 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20043806 0.98 S100B (0.65) S100BMAPTALDH1A1MEN1KMT2A
SCHEMBL30900439 0.85 GAA (0.64) S100BMAPTALDH1A1MEN1KMT2A
SCHEMBL1527203 0.85 GAA (0.64) S100BMAPTALDH1A1MEN1KMT2A
SCHEMBL2923577 0.84 GAA (0.67) S100BMAPTALDH1A1MEN1KMT2A
Hydrochloric Acid SCHEMBL1527191 0.83 MAPT (0.62) S100BMAPTALDH1A1MEN1KMT2A
SCHEMBL30545196 0.83 LGMN (0.62) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL21760107 0.83 ADRB1 (0.71) MAPTGAAHTTRAD52RECQL
SCHEMBL375628 0.83 LGMN (0.62) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL8864170 0.82 GAA (0.65) S100BMAPTALDH1A1MEN1KMT2A
SCHEMBL6223137 0.82 GAA (0.65) S100BMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107250172-B Modified conjugated diene polymer, method for producing same, and modified conjugated diene polymer composition 旭化成株式会社 2021-04-09 CN disclosed
WO-2014118092-A2 DYE COMPOSITION COMPRISING AT LEAST ONE PARTICULAR LIPOPHILIC META-PHENYLENEDIAMINE COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES L'OREAL (FR) 2014-08-07 WO disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 S100B 1812/4885MAPT 2598/4885ALDH1A1 1506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.